InvestorsHub Logo
Followers 8
Posts 1167
Boards Moderated 1
Alias Born 01/07/2008

Re: philsdaddy post# 894

Thursday, 10/22/2009 10:44:46 AM

Thursday, October 22, 2009 10:44:46 AM

Post# of 18493
Me too, this is huge!

"ESI allows us to leverage the previously unrecognized value of our non-infectious disease research into a new asset that positions us to be an important participant in the emerging exosome industry. We also maintain the option of installing an independent management team at ESI and if appropriate in the future, may spin out part or all of ESI as a means to achieve fuller valuation for Aethlon Medical (AEMD:$0.36,00$0.04,0012.50%) shareholders," concluded Joyce.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News